Dual Mycobacterial Infection with Tuberculosis and Leprosy: A Case Highlighting Diagnostic and Programmatic Challenges in Endemic Settings
DOI:
https://doi.org/10.55489/njcm.170420266225Keywords:
Tuberculosis, Multidrug-Resistant, Lepromatous Leprosy, Osteomyelitis, LymphadenopathyAbstract
Introduction: Tuberculosis (TB) and leprosy are chronic infectious diseases caused by Mycobacterium species and remain significant public health concerns in endemic countries like India. According to the World Health Organization Global TB Report 2025, India continues to carry one of the highest TB burdens globally. Although both diseases are well known individually, their simultaneous occurrence is rarely reported in modern literature. Co-infection poses diagnostic and therapeutic challenges, particularly due to the shared use of rifampicin in treatment regimens.
Case Presentation: A 62-year-old female farmer presented with fever, multiple painless cervical swellings with yellowish discharge, swelling of the right thumb, and multiple ulcerative skin lesions over the extremities. Clinical examination revealed matted cervical lymphadenopathy, nodular swellings on the hand, hypo- and hyper-pigmented macular lesions on the back, and thickened ulnar nerve. Investigations showed anemia and raised inflammatory markers. Ziehl-Neelsen staining and histopathology confirmed lepromatous leprosy, while fine needle aspiration cytology and CBNAAT of cervical lymph nodes confirmed tuberculous lymphadenitis without rifampicin resistance. Imaging revealed osteomyelitis of the right thumb consistent with tubercular involvement. The patient was treated with multidrug therapy for leprosy along with standard anti-tubercular therapy and showed clinical improvement on follow-up.
Conclusion: Concurrent TB and leprosy, though uncommon, require early recognition and evaluation for rifampicin resistance to ensure appropriate treatment and prevent drug resistance. Routine screening for TB in patients diagnosed with leprosy is recommended in endemic regions.
References
World Health Organization. Tuberculosis country profile: India [Internet]. Geneva: World Health Organization; [cited 2026 Mar 6]. Available from: https://worldhealthorg.shinyapps.io/tb_profiles/?_inputs_&tab=%22tables%22&lan=%22EN%22&iso3=%22IND%22&entity_type=%22country%22
Ridell M, Eriksson M. Tuberculosis and Leprosy in the Past. Int J Mycobacteriol. 2025 Oct 1;14(4):320-324. DOI: https://doi.org/10.4103/ijmy.ijmy_193_25 PMid:41411379
Rawson TM, Anjum V, Hodgson J, Rao AK, Murthy K, Rao PS, Subbanna J, Rao PV. Leprosy and tuberculosis concomitant infection: a poorly understood, age-old relationship. Lepr Rev. 2014 Dec;85(4):288-295. DOI: https://doi.org/10.47276/lr.85.4.288 PMid:25675653
World Health Organization. Global tuberculosis report 2025 [Internet]. Geneva: World Health Organization; 2025 [cited 2026 Feb 21]. Available from: https://www.who.int/teams/global-programme-on-tuberculosis-and-lung-health/tb-reports/global-tuberculosis-report-2025
World Health Organization. Global leprosy (Hansen disease) update, 2023: Elimination of leprosy disease is possible - Time to act! WER No 37, 2024, 99. Geneva: World Health Organization; 2024. p519. Available from: https://iris.who.int/server/api/core/bitstreams/4b0aea60-d4ec-4228-946e-773d864e1b2d/content
Donoghue HD, Marcsik A, Matheson C, Vernon K, Nuorala E, Molto JE, et al. Co-infection of Mycobacterium tuberculosis and Mycobacterium leprae in human archaeological samples: a possible explanation for the historical decline of leprosy. Proc Biol Sci. 2005 Feb 22;272(1561):389-94. DOI: https://doi.org/10.1098/rspb.2004.2966 PMid:15734693 PMCid:PMC1634979
Crespo F, White J, Roberts C. Revisiting the tuberculosis and leprosy cross-immunity hypothesis: Expanding the dialogue between immunology and paleopathology. Int J Paleopathol. 2019 Sep;26:37-47. DOI: https://doi.org/10.1016/j.ijpp.2019.05.005 PMid:31185376
K C SR, K C G, Gyawali P, Singh M, Sijapati MJ. Leprosy - eliminated and forgotten: a case report. J Med Case Rep. 2019 Sep 1;13(1):276. DOI: https://doi.org/10.1186/s13256-019-2198-1 PMid:31472695 PMCid:PMC6717627
World Health Organization. WHO consolidated operational handbook on tuberculosis: module 4: treatment and care [Internet]. Geneva: World Health Organization; 2025 [cited 2026 Jan 15]. Available from: https://www.who.int/publications/i/item/9789240108141
Rajagopala S, Devaraj U, D'souza G, Aithal VV. Co-infection with M. tuberculosis and M. leprae-case report and systematic review. J Mycobac Dis. 2012 Jun;2(4):1-5.
Keragala BSDP, Herath HMMTB, Janapriya GHDC, Vanitha S, Balendran T, Janani T, et al. Coexistence of mycobacterial infections - Mycobacterium tuberculosis and Mycobacterium leprae - in Sri Lanka: a case series. J Med Case Rep. 2020 Jul 16;14(1):101. DOI: https://doi.org/10.1186/s13256-020-02413-w PMid:32669124 PMCid:PMC7364491
Rakotoarisaona MF, Razafimaharo TI, Sendrasoa FA, Andrianarison M, Razanakoto NH, Ratovonjanahary VT, et al. Coinfection with Leprosy and Tuberculosis: A Case Series in Malagasy Patients. Infect Drug Resist. 2024 Apr 15;17:1507-1513. DOI: https://doi.org/10.2147/IDR.S458888 PMid:38645889 PMCid:PMC11027919
Soto JA, Gálvez NMS, Andrade CA, Ramírez MA, Riedel CA, Kalergis AM, Bueno SM. BCG vaccination induces cross-protective immunity against pathogenic microorganisms. Trends Immunol. 2022 Apr;43(4):322-335. DOI: https://doi.org/10.1016/j.it.2021.12.006 PMid:35074254
Gupta P, Pandey A, Deepak D, Suri A. Tuberculosis and leprosy co-infection: Points to remember. Lung India. 2025 Nov 1;42(6):551-554. DOI: https://doi.org/10.4103/lungindia.lungindia_607_24 PMid:41129581 PMCid:PMC12617594
Hohmann N, Voss-Böhme A. The epidemiological consequences of leprosy-tuberculosis co-infection. Math Biosci. 2013 Feb;241(2):225-237. DOI: https://doi.org/10.1016/j.mbs.2012.11.008 PMid:23246805
Wagenaar I, Post E, Brandsma W, Bowers B, Alam K, Shetty V, et al. Effectiveness of 32 versus 20 weeks of prednisolone in leprosy patients with recent nerve function impairment: A randomized controlled trial. PLoS Negl Trop Dis. 2017 Oct 4;11(10):e0005952. DOI: https://doi.org/10.1371/journal.pntd.0005952 PMid:28976976 PMCid:PMC5643133
World Health Organization. A guide for surveillance of antimicrobial resistance in leprosy: 2017 update. New Delhi: World Health Organization, Regional Office for South-East Asia; 2017. [cited 2025 Oct 11]. Available from: https://www.who.int/publications/i/item/9789290225492
Adil M, Amin SS, Naaz S, Sharmeen A. Leprosy-tuberculosis co-infection: A case series. Indian J Dermatol Venereol Leprol. 2026 Jan 28:1-6. DOI: https://doi.org/10.25259/IJDVL_1172_2025 PMid:41655090
Gupta R, Garg K, Bhalla M, Janmeja AK. Multidrug-resistant tuberculosis and leprosy: An unsolved mystery. Lung India. 2017 Jul-Aug;34(4):364-367. DOI: https://doi.org/10.4103/lungindia.lungindia_451_15 PMid:28671168 PMCid:PMC5504894
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Bhumika Vaishnav, Bhavin Sanghani, Kshitij, Gursimar Pal Singh
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
The authors retain the copyright of their article, with first publication rights granted to Medsci Publications.
